Kim Diamond

Kim Diamond is a seasoned communications professional with extensive experience in the biopharmaceutical industry. Currently serving as Vice President of Communications and Investor Relations at SpringWorks Therapeutics since August 2018, Kim has played a key role in advancing the company's mission to deliver precision medicines for severe rare diseases and cancer. Previous positions include Executive Director of Corporate Communications at Alexion Pharmaceuticals from January 2011 to May 2018, Director of Public Relations at OSI Pharmaceuticals from February 2006 to December 2011, and Vice President at Edelman from June 1999 to February 2006. Kim holds a Bachelor of Arts degree from Middlebury College, earned between 1991 and 1994.